Several European cannabis start-ups are preparing to launch initial public offerings in New York, capitalizing on a US proposal to reclassify marijuana as a less dangerous drug and recent decriminalization efforts in Germany. This move comes despite depressed share prices among larger players in the sector. London-based Grow Group, a medical cannabis distributor, aims to …